Emergent BioSolutions Inc. — Director's Dealing 2016

Jan 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-12-30

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-30	Common Stock	M	21600	$8.43	Acquired	35333	Direct
2015-12-30	Common Stock	S	21600	$40.00	Disposed	13733	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-30	Stock Option	$8.43	M	21600	Disposed	2017-06-13	Common Stock (21600)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on June 14, 2007.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.01, inclusive.

F4: The option vested in three equal installments in June 2008, 2009 and 2010.